Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
News: $KOOL Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee
RANCHO CORDOVA, Calif. , Oct. 2, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary (the "Company"), announced today it has...
Find out more KOOL - Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee
News: $KOOL Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products
RANCHO CORDOVA, Calif. , Sept. 9, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary (the "Company"), filed a Form 8-K last...
In case you are interested KOOL - Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products
News: $KOOL ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing
RANCHO CORDOVA, Calif. , June 18, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today announced that it has received Health Canada approval of its nex...
Read the whole news https://marketwirenews.com/news-releases/thermogenesis-receives-health-canada-approval-of-its-next-generation-axp-xae-ii-system-for-cord-blood-processing-8374208.html
News: $KOOL ThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine Symposium
RANCHO CORDOVA, Calif. , June 5, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today announced that it will participate in and exhibit its novel PXP® System, for point-of...
Find out more https://marketwirenews.com/news-releases/thermogenesis-to-participate-in-the-orthobiologic-institute-s-10th-annual-prp-regenerative-medicine-symposium-8303292.html
News: $KOOL Cesca Therapeutics Announces 1-for-10 Reverse Split Of Common Stock
RANCHO CORDOVA, Calif. , June 4, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced that it has amended its Sixth Amended and Restated Certificate of Incorp...
In case you are interested https://marketwirenews.com/news-releases/cesca-therapeutics-announces-1-for-10-reverse-split-of-common-stock-8297838.html
News: $KOOL Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2019 and Host a Conference Call on May 14
RANCHO CORDOVA, Calif. , May 7, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that the Company will release its financial results fo...
Read the whole news https://marketwirenews.com/news-releases/cesca-therapeutics-to-announce-financial-results-for-the-first-quarter-ended-march-31-2019-and-host-a-conference-call-on-may-14-8131908.html
Great news, but nobody seems to realize it... My 0,33´s looking better day by day (by day) :)
Very nice PR! Gonna see a big move upward tomorrow, lovely thin low floater...
News: $KOOL ThermoGenesis Corp® Completes Construction and Qualification of In-House Clean Room for Assembly of All X-Series(TM) Cell Processing Disposables
RANCHO CORDOVA, Calif. , Jan. 21, 2019 /PRNewswire/ -- ThermoGenesis Corp, a private corporation owned by Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced the ...
Find out more https://marketwirenews.com/news-releases/thermogenesis-corp-xae-completes-construction-and-qualification-of-in-house-clean-room-for-assembly-of-all-x-series-tm-cell-processing-disposables-7331542.html
* * $KOOL * *
Link to Video- watch analysis by clicking HERE
going to pass $1 soon and might be 3 dollars later, very low os and generate money millions with fda approval, I think KOOL will be bought out it is so cheap with huge potential, all my opinion
I detect them early, sometimes also trade the pops of course.
As posted before, I guess you´re a smart guy. No need to have such an attitude making newbies buy on "it´s going to the moon" in bold letters.
Trade the Pops, Dont be a Tree Hugger!
No complaints, congrats. I use to own them very early.
I guess we both make $$, no need to try to cheat others and post 5-10 nonsense posts in a row...
I trade Breakouts then run to the Hills with the $$$ LOL ! End Of story GLTY
Congrats!
I just don´t like your style trying to make people buy "0,80 eod" - "1-2$ next week" - not surprised you didn´t answer my questions. Guys like you are part of the game - and some matches are very dirty (...)
My Bad .52 sorry Getting confused trading soo many Stocks! Ive been trading PPCB since .13 yesterday Check it Out!!! $$$
Congrats! Didn´t expect anything else from your side - it never traded 0,55 btw...
Just ask myself about your intentions?!? Do you believe what you post in here (in BOLD letters)?!? Are you glad you made others buy 0,50+ on your "advice"?!?
Got Out @ .55 Last Week LOL $$$
Wasup with your front load pump or whatever you tried to suggest last week...
.52 break could be today then .76 is next attack
next big walls are .76 and 1.32 --- Once it clears .52
break .52 we start a new run -- next big wall are .76 and 1.32
Next wall based on charts is .58 to .62
Next week, its being front loaded with huge Block buys in the .47s .48s .49s $$$
And your technical breakout analysis brought you to the conclusion it's going to trade around 0,80 eod...?!?
Maybe because its a Nasdaq traded stock! traders would rather post on stocktwits rather than a ghost town! LOL
I Pump strictly on Technical Breakouts only!! $$$
Maybe it´s one of those boards with no need of unrealistic figures and bold letter pumping to "attract" people...
Is it 2.00 - 2.10 yet? LOL BOOM!! Is this one of those boards that sucks when price explodes Bigly haha!!! http://schrts.co/edLGCv
Massive Buying has begun BAbe >>> $$$$ push it to the .80's today $$$$
Loaded more from .4699 Fun begins above .47 $$$
Gap being filled @ .465 - .47 Lets go to 1.00 $$$$$
next wall .58 to .62 we should see by Tomorrow
I got me 25K shares at .255
Finally, been waiting on this one a while lol
at .46 break we should see .52 to .62 today
Next wall based on charts is .58 to .62
Good morning All
Followers
|
39
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
843
|
Created
|
09/21/08
|
Type
|
Free
|
Moderators |
Thermogenesis Corp. (KOOL)
Company Profile:
ThermoGenesis Corp. engages in the design, manufacture, and marketing of automated and semi-automated devices, and single-use processing disposables primarily in Asia, the United States, and Europe. The company?s products enable hospitals and blood banks to manufacture a therapeutic dose of stem cells, wound healing proteins, or growth factors from a single unit of cord blood or the patient?s own blood. Its products include BioArchive System, an automated cryogenic system used in stem cell therapy to cryopreserve and archive stem cells and tissue for future transplant and treatment; AutoXpress Platform, which isolates and retrieves stem cells from umbilical cord blood; MarrowXpress, that isolates and retrieves stem cells from bone marrow aspirate; and CryoSeal Fibrin Sealant System, an automated system used to prepare an autologous hemostatic surgical sealant from a patient?s own blood or from a single donor. The company?s product also includes Thrombin Processing Device, a sterile blood processing disposable that prepares activated thrombin from a small aliquot of plasma. ThermoGenesis Corp. was founded in 1985 and is based in Rancho Cordova, California.
Advanced technologies, advancing stem cell sciences. At ThermoGenesis, we know how valuable stem cells can be-and that there is only one chance to get it right. So for over 20 years, we've dedicated ourselves to providing clinicians, researchers, hospitals, and blood banks with systems designed to handle stem cells with the highest levels of precision, safety, and confidence. Our dedication to the regenerative medicine market has inspired the creation of a wholly-owned subsidiary, Vantus Inc., a veterinary stem cell laboratory service. Vantus's collaboration with the UC Davis School of Veterinary Medicine's Center for Equine Health and its Stem Cell Regenerative Medicine group will give us the means to conduct research and development to enhance the collecting, processing, and storing of stem cells from a variety of sources (eg, blood, bone marrow, tissue). It is our mission that the experience we gain in the veterinary stem cell market will provide us with a greater understanding in development of therapeutic products for human injuries and diseases, and speed our entry into these evolving markets. To learn more, please visit www.vantuslabs.com. From today's cells to tomorrow's solutions, count on our technologies to help you put a new world of innovative therapies into circulation. STEM CELL TECHNOLOGIES- http://www.thermogenesis.com/stem-cell-technologies.aspx ---AXP™ AutoXpress™--- Cord blood is transferred into the processing bagset which is placed in the AXP device and then centrifuged. During centrifugation, component stratification occurs ---MarrowXpress™--- The innovative MarrowXpress™ (MXP) System defines a new processing standard for isolating and retrieving stem cells from bone marrow aspirate. STEM CELL PRESERVATION- http://www.thermogenesis.com/stem-cell-bioarchive.aspx ---BioArchive® System--- The BioArchive® Cryopreservation, Tracking, and Retrieval System is the industry's leading liquid nitrogen cryopreservation and storage system for stem cell samples. Using proven, computer-controlled technology, it provides the ultimate in performance and protection for today's invaluable cord blood samples, and tomorrow's critical stem cell needs. BioArchive® is the preferred system for cord blood banks worldwide SURGICAL WOUND CARE http://www.thermogenesis.com/wound-care.aspx ---CryoSeal® FS--- The advanced CryoSeal® FS System delivers a new generation of performance for the production of fibrin sealant. The system safely and conveniently extracts high-quality fibrinogen-rich cryoprecipitate and thrombin from a single unit of autologous or allogenic plasma in approximately 60 minutes*. ---Thrombin Processing Device (TPD™)--- The advanced Thrombin Processing Device (TPD™) provides busy operating rooms and other fast-paced environments with a rapid, safe, easy-to-use method for producing active human thrombin from either plasma or whole blood. ULTRA RAPID PLASMA FREEZERS AND THAWERS http://www.thermogenesis.com/thermoline.aspx ---ThermoLine™ Plasma Freezing Systems--- ThermoLine™ ultra-rapid plasma freezing systems enable accelerated, semi-automated, cost-effective freezing of up to 84 units of blood plasma. These unique ultra-rapid freezers are easy-to-use, convenient, and use an environmentally-friendly refrigerant (non CFC, non HCFC) and heat transfer fluid. ---ThermoLine™ Blood Component Thawing Systems--- Our thawing systems are automated, easy to operate and maintain. The units are sealed from the outside environment by a deck with flexible snap-seal pockets that minimize the potential for bacterial or viral airborne contamination of the water, or rapid water evaporation. Offered in two-, four-, and ten-bag capacities, the systems can also accommodate bags of various sizes. ThermoLine™ Thawing Systems are cleared by regulatory agencies to thaw plasma and glycerolized red blood cells in ≈ 12 minutes and ≈ 45 minutes respectively. |
Thermogenesis Corp.
Cash: 22M
Debt: 0
Share Structure:
AS: 80M
OS: 56M (sept 30 10Q)
Revenues:
2008: $21,946,000
2007: $16,751,000
2006: $12,048,000
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |